Global Biomarker Market Research Report 2024

Publication ID:

PB505242438

Publication Date:

May 1, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention."
The global Biomarker market was valued at US$ 28570 million in 2023 and is anticipated to reach US$ 68010 million by 2030, witnessing a CAGR of 12.7% during the forecast period 2024-2030.
North American market for Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biomarker in Diagnostics Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biomarker include F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG, General Electric, Johnson & Johnson Services, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH and QIAGEN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker.
Report Scope
The Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd.
Abbott
Epigenomics AG
General Electric
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthcare GmbH
QIAGEN
Segment by Type
Consumables
Service
Segment by Application
Diagnostics Development
Drug Discovery and Development
Disease-Risk
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Service
1.3 Market by Application
1.3.1 Global Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics Development
1.3.3 Drug Discovery and Development
1.3.4 Disease-Risk
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Market Perspective (2019-2030)
2.2 Biomarker Growth Trends by Region
2.2.1 Global Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Biomarker Market Dynamics
2.3.1 Biomarker Industry Trends
2.3.2 Biomarker Market Drivers
2.3.3 Biomarker Market Challenges
2.3.4 Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker Players by Revenue
3.1.1 Global Top Biomarker Players by Revenue (2019-2024)
3.1.2 Global Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biomarker Revenue
3.4 Global Biomarker Market Concentration Ratio
3.4.1 Global Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Revenue in 2023
3.5 Biomarker Key Players Head office and Area Served
3.6 Key Players Biomarker Product Solution and Service
3.7 Date of Enter into Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Breakdown Data by Type
4.1 Global Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Biomarker Forecasted Market Size by Type (2025-2030)
5 Biomarker Breakdown Data by Application
5.1 Global Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biomarker Market Size (2019-2030)
6.2 North America Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biomarker Market Size by Country (2019-2024)
6.4 North America Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarker Market Size (2019-2030)
7.2 Europe Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biomarker Market Size by Country (2019-2024)
7.4 Europe Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarker Market Size (2019-2030)
9.2 Latin America Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biomarker Market Size by Country (2019-2024)
9.4 Latin America Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Detail
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Biomarker Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Biomarker Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Biomarker Introduction
11.2.4 Abbott Revenue in Biomarker Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Epigenomics AG
11.3.1 Epigenomics AG Company Detail
11.3.2 Epigenomics AG Business Overview
11.3.3 Epigenomics AG Biomarker Introduction
11.3.4 Epigenomics AG Revenue in Biomarker Business (2019-2024)
11.3.5 Epigenomics AG Recent Development
11.4 General Electric
11.4.1 General Electric Company Detail
11.4.2 General Electric Business Overview
11.4.3 General Electric Biomarker Introduction
11.4.4 General Electric Revenue in Biomarker Business (2019-2024)
11.4.5 General Electric Recent Development
11.5 Johnson & Johnson Services, Inc.
11.5.1 Johnson & Johnson Services, Inc. Company Detail
11.5.2 Johnson & Johnson Services, Inc. Business Overview
11.5.3 Johnson & Johnson Services, Inc. Biomarker Introduction
11.5.4 Johnson & Johnson Services, Inc. Revenue in Biomarker Business (2019-2024)
11.5.5 Johnson & Johnson Services, Inc. Recent Development
11.6 Thermo Fisher Scientific Inc.
11.6.1 Thermo Fisher Scientific Inc. Company Detail
11.6.2 Thermo Fisher Scientific Inc. Business Overview
11.6.3 Thermo Fisher Scientific Inc. Biomarker Introduction
11.6.4 Thermo Fisher Scientific Inc. Revenue in Biomarker Business (2019-2024)
11.6.5 Thermo Fisher Scientific Inc. Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Detail
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Biomarker Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Biomarker Business (2019-2024)
11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 Siemens Healthcare GmbH
11.8.1 Siemens Healthcare GmbH Company Detail
11.8.2 Siemens Healthcare GmbH Business Overview
11.8.3 Siemens Healthcare GmbH Biomarker Introduction
11.8.4 Siemens Healthcare GmbH Revenue in Biomarker Business (2019-2024)
11.8.5 Siemens Healthcare GmbH Recent Development
11.9 QIAGEN
11.9.1 QIAGEN Company Detail
11.9.2 QIAGEN Business Overview
11.9.3 QIAGEN Biomarker Introduction
11.9.4 QIAGEN Revenue in Biomarker Business (2019-2024)
11.9.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

F. Hoffmann-La Roche Ltd.
Abbott
Epigenomics AG
General Electric
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthcare GmbH
QIAGEN

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂